NCT05656092View on ClinicalTrials.gov

A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

PHASE3CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

December 19, 2024

Study Completion Date

December 19, 2024

Conditions
Gastric Ulcer
Interventions
DRUG

HIP0612

Test drug

DRUG

HPP2202

Placebo drug

DRUG

RLD2204

Reference drug

DRUG

HPP2201

Placebo drug

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY